DEBN Overview

  • Founded
  • 2017
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.22M
Latest Deal Amount
  • Investors
  • 3

DEBN General Information


Developer of medical devices designed to treat TRUS-Bx related infectious complications. The company's device consists of the polymer-coated biopsy needle and anesthesia needle that release the drugs directly to the prostate during the procedure permitting the co-administration of various antibiotics, thereby broaden their spectrum of activity and potentially reduce the number of infectious complications, enabling the patient to reduce the risk of infections who undergo this procedure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Medical Supplies
Therapeutic Devices
Surgical Devices
Primary Office
  • Szafarnia 11/F8 street
  • Gdańsk, 80-755
  • Poland
+48 58 000 00 00

DEBN Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DEBN Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 01-Jan-2020 $2.22M 00.00 Completed Generating Revenue
4. Grant 01-Jan-2019 00000 00000 Completed Generating Revenue
3. Seed Round 12-Feb-2018 00000 00000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2018 $11.9K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2017 $11.9K $11.9K Completed Startup
To view DEBN’s complete valuation and funding history, request access »

DEBN Executive Team (3)

Name Title Board Seat Contact Info
Michał Kruzycki Co-Founder, General Manager, Board Member & Chief Executive Officer
Marcin Sieczkowski MD Co-Founder & Medical Doctor and Certified Urologist
Artur Gibas MD Co-Founder
To view DEBN’s complete executive team members history, request access »

DEBN Board Members (1)

Name Representing Role Since
Michał Kruzycki DEBN Co-Founder, General Manager, Board Member & Chief Executive Officer 000 0000
To view DEBN’s complete board members history, request access »

DEBN Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DEBN Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kvarko Venture Capital Minority 000 0000 000000 0
MIT Enterprise Forum CEE Accelerator/Incubator 000 0000 000000 0
Alfabeat Venture Capital Minority 000 0000 000000 0
To view DEBN’s complete investors history, request access »